000 01409 a2200385 4500
005 20250513090619.0
264 0 _c19960621
008 199606s 0 0 eng d
022 _a0021-972X
024 7 _a10.1210/jcem.81.5.8626860
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrow, D R
245 0 0 _aAntiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cMay 1996
300 _a1933-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBone Density
650 0 4 _aEndometriosis
_xdrug therapy
650 0 4 _aEndometrium
_xpathology
650 0 4 _aEstradiol
_xblood
650 0 4 _aFemale
650 0 4 _aHormone Antagonists
_xtherapeutic use
650 0 4 _aLeuprolide
_xadministration & dosage
650 0 4 _aMacaca fascicularis
650 0 4 _aMifepristone
_xadministration & dosage
650 0 4 _aProgestins
_xantagonists & inhibitors
650 0 4 _aTime Factors
650 0 4 _aVagina
_xpathology
700 1 _aWilliams, R F
700 1 _aHsiu, J G
700 1 _aHodgen, G D
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 81
_gno. 5
_gp. 1933-9
856 4 0 _uhttps://doi.org/10.1210/jcem.81.5.8626860
_zAvailable from publisher's website
999 _c8625906
_d8625906